Milestone News

Milestone Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference

Montreal, QC, CA, March 12, 2018 – Milestone Pharmaceuticals Inc. today announced that Joseph G. Oliveto, President and Chief Executive Officer, will present at the Cowen and Company 38th Annual Health Care Conference in Boston on Wednesday, March 14, 2018 at 10:00 a.m. Eastern Time.

 

About Milestone Pharmaceuticals
Milestone, with headquarters in Montreal, Canada and a US subsidiary in Charlotte, NC, is a clinical stage drug development company focused on developing etripamil, a calcium channel blocker intended to provide fast-acting and short-acting treatment of PSVT episodes. For more information, please visit www.milestonepharma.com.

 

Contact
David Pitts
Argot Partners
212-600-1902
david@argotpartners.com